Background: Although more than 150,000 implantable cardioverter defibrillators (ICDs) are implanted yearly worldwide, only few studies systematically examined complications of ICD therapy in large ...

Implantable cardiac devices play a significant role in decreasing the morbidity and mortality in patients with cardiovascular disease. Tissue-device interactions leading to systemic hypersensitivity ...

Dublin, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The "Implantable Cardioverter Defibrillators (ICD) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key ...

Augusta Health, a leading health care provider in the Shenandoah Valley, now proudly offers to cardiac patients a less invasive, highly reliable implantable defibrillator: the Boston Scientific S-ICD® ...

A standard test of the implantable cardioverter defibrillator (ICD) is linked to significant thought-processing problems that improve for most patients within a year after the device is inserted, ...

The indications for ICD implantation continue to expand; however, these devices are associated with complications related to the implantation procedure itself and morbidity caused by the normal and ...

Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Global Implantable Cardioverter Defibrillators Market by Product Type, by Type, by NYHA Class, by End-User, and By Region" report has been added to ...

Heart failure is a deadly disease. Every year, tens of thousands of patients die from this condition, many of them suddenly. Efforts aimed at reducing mortality centered initially on antagonizing the ...